La Regina, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 778
AS - Asia 712
EU - Europa 666
SA - Sud America 147
Continente sconosciuto - Info sul continente non disponibili 47
AF - Africa 19
OC - Oceania 2
Totale 2.371
Nazione #
US - Stati Uniti d'America 747
SG - Singapore 324
IT - Italia 163
DE - Germania 144
CN - Cina 142
BR - Brasile 119
SE - Svezia 99
FR - Francia 71
FI - Finlandia 68
VN - Vietnam 61
BD - Bangladesh 50
JP - Giappone 25
GB - Regno Unito 23
IN - India 23
NL - Olanda 22
HK - Hong Kong 21
ID - Indonesia 20
IE - Irlanda 18
RU - Federazione Russa 15
MX - Messico 12
AR - Argentina 11
CA - Canada 10
KR - Corea 8
PL - Polonia 8
CO - Colombia 6
CZ - Repubblica Ceca 5
ES - Italia 5
TR - Turchia 5
UA - Ucraina 5
ZA - Sudafrica 5
IQ - Iraq 4
PK - Pakistan 4
VE - Venezuela 4
AT - Austria 3
EC - Ecuador 3
EG - Egitto 3
JO - Giordania 3
KE - Kenya 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BE - Belgio 2
CH - Svizzera 2
CR - Costa Rica 2
JM - Giamaica 2
MA - Marocco 2
MM - Myanmar 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.325
Città #
Singapore 166
San Jose 131
Munich 104
Ashburn 87
Chandler 61
Helsinki 51
Rome 37
Beijing 33
New York 26
Hefei 25
Los Angeles 25
Tokyo 24
Boardman 21
Frankfurt am Main 19
Hong Kong 19
Jakarta 19
Lauterbourg 19
Dublin 18
Ho Chi Minh City 18
Council Bluffs 17
Hanoi 16
Hyderabad 15
Bologna 13
Boston 12
Moscow 11
San Mateo 11
St Louis 11
Milan 10
Buffalo 9
Princeton 9
Seoul 8
São Paulo 8
Düsseldorf 7
Kent 7
London 7
Paris 7
Santa Clara 7
Turku 7
Warsaw 7
Aprilia 6
Brooklyn 6
Dallas 6
Houston 6
Lappeenranta 6
Portsmouth 6
Mexico City 5
Amsterdam 4
Andover 4
Augusta 4
Bexley 4
Chicago 4
Johannesburg 4
Nuremberg 4
São Gonçalo 4
The Dalles 4
Ankara 3
Atlanta 3
Belo Horizonte 3
Bogotá 3
Brno 3
Cairo 3
Campinas 3
Charleston 3
Charlotte 3
Columbus 3
Curitiba 3
Da Nang 3
Goiânia 3
Haiphong 3
Montreal 3
Nairobi 3
Newark 3
North Bergen 3
Orem 3
Poplar 3
Rancho Palos Verdes 3
Santos 3
Seattle 3
Shanghai 3
Toronto 3
Wattenheim 3
Baku 2
Bergamo 2
Betim 2
Brasília 2
Brussels 2
Buenos Aires 2
Can Tho 2
Cattolica 2
Chennai 2
Draper 2
Erbil 2
Florianópolis 2
Franca 2
Guangzhou 2
Guayaquil 2
Hangzhou 2
Irpin 2
Jyväskylä 2
Karachi 2
Totale 1.295
Nome #
Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment 252
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 147
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 145
Targeting the Grb2 cSH3 domain: Design, synthesis and biological evaluation of the first series of modulators 119
Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor 110
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent 105
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains 105
Small molecule inhibitors of kdm5 histone demethylases increase the radiosensitivity of breast cancer cells overexpressing JARID1B 103
Targeting CBP and p300: Emerging Anticancer Agents 102
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 101
Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability 101
Design, synthesis and biological evaluation of PDZ1 targeting NHERF1 inhibitors as anticancer agents 100
Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor 95
Emerging Direct Targeting β-Catenin Agents 95
New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors 93
RS6077 induces mitotic arrest and selectively activates cell death in human cancer cell lines and in a lymphoma tumor in vivo 90
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents 89
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 89
Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy 87
Indolylarylsulfones as novel potent anti-HIV-1 agents 84
Indolylarylsulfones as novel potent anti-HIV-1 agents 80
Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities 70
Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment 9
Totale 2.371
Categoria #
all - tutte 10.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202284 0 0 0 0 0 0 0 41 3 1 24 15
2022/2023191 37 21 16 6 25 17 9 23 26 0 8 3
2023/2024127 3 26 3 5 5 10 1 2 13 5 33 21
2024/2025675 13 4 27 33 50 47 100 43 93 86 109 70
2025/20261.207 137 52 60 128 150 58 164 65 101 97 114 81
2026/202787 48 39 0 0 0 0 0 0 0 0 0 0
Totale 2.371